Yu Shan
Founder chez SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Fortune : 54 M $ au 31/03/2024
Profil
Yu Shan a fondé Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Il est actuellement directeur général et directeur exécutif de Shenzhen Hepalink Pharmaceutical Group Co. Ltd. et partenaire exécutif de Urumqi Shuidishichuan Equity Investment Partnership LP. Il siège également au conseil d'administration de Chengdu Hepatunn Pharmaceutical Co. Ltd. et de Shenzhen Duopule Industrial Development Co., Ltd. Il est titulaire d'un diplôme de premier cycle de l'université de Pékin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 46 425 600 ( 3,72% ) | 54 M $ | 31/03/2024 |
Postes actifs de Yu Shan
| Sociétés | Poste | Début |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21/04/1998 |
| Urumqi Shuidishichuan Equity Investment Partnership LP | Corporate Officer/Principal | - |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
 Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Director/Board Member | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Director/Board Member | 13/01/2014 |
Formation de Yu Shan
| Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Urumqi Shuidishichuan Equity Investment Partnership LP | |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
